FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

788331007: Product containing polatuzumab vedotin in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3779942015 Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779943013 Polatuzumab vedotin-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779942015 Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779943013 Polatuzumab vedotin-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polatuzumab vedotin true Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Is a Polatuzumab vedotin-containing product true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Polatuzumab vedotin only product in parenteral dose form Is a True Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start